ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 3210 for:    Dementia

Polyphenols and Risk of Dementia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03286608
Recruitment Status : Completed
First Posted : September 18, 2017
Last Update Posted : September 18, 2017
Sponsor:
Information provided by (Responsible Party):
Jean-François Dartigues, University of Bordeaux

Brief Summary:
This project aims to leverage existing data from a large observational prospective study on dementia, the Three-City study, to investigate the relationship between intakes of polyphenols and the risk to develop dementia in the 12 years following dietary assessment.

Condition or disease Intervention/treatment
Diet, Polyphenols, Flavonoids, Stilbenes, Aged, Dementia, Alzheimer's Disease, Epidemiology Other: observational study (no intervention)

Detailed Description:
The study sample includes 1,329 subjects followed for up to 12 years fro dementia after dietary assessment. The aim is to identify a pattern of polyphenol intake (based on 26 flavonoid and non-flavonoid polyphenol subclasses ascertained using a 24-hour dietary recall) associated with the risk of dementia and AD over 12 years in the 3C Bordeaux cohort.

Study Type : Observational
Actual Enrollment : 1329 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pattern of Polyphenol Intake and the Long-term Risk of Dementia in Older Persons
Actual Study Start Date : January 1, 1999
Actual Primary Completion Date : December 31, 2015
Actual Study Completion Date : December 31, 2015



Intervention Details:
  • Other: observational study (no intervention)
    Statistical association between adherence to a pattern of polyphenol intake and the risk to develop dementia and Alzheimer's disease over 12 years
    Other Name: pattern of polyphenol intake


Primary Outcome Measures :
  1. incidence of dementia [ Time Frame: 12 years ]
    incident cases of dementia diagnosed by the expert committee of neurologists at follow-up visits


Secondary Outcome Measures :
  1. incidence of Alzheimer's disease [ Time Frame: 12 years ]
    dementia with probable or possible Alzheimer etiology



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
population of older persons from the community, aged 65 years or more, living in the Bordeaux area (France)
Criteria

Inclusion Criteria:

  • 65 years or more, live in Bordeaux area (France)

Exclusion Criteria:

  • with dementia at the time of dietary assessment in year 2001-2002

Responsible Party: Jean-François Dartigues, Pr, University of Bordeaux
ClinicalTrials.gov Identifier: NCT03286608     History of Changes
Other Study ID Numbers: Three-City study Bordeaux
First Posted: September 18, 2017    Key Record Dates
Last Update Posted: September 18, 2017
Last Verified: September 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders